Purpose of Privacy Statement
Bristol-Myers Squibb and AstraZeneca have entered into a Codevelopment and Copromotion Agreement for certain
compound(s). Bristol-Myers Squibb and AstraZeneca respect the privacy of visitors to this Web site and understand the importance of protecting your personal information. Bristol-Myers Squibb and AstraZeneca will not transfer, sell, or rent your personally identifiable information, except as specifically provided in this Privacy Statement. This Privacy Statement applies to personally identifiable information about you, such as name, postal address, telephone number, e-mail address, date of birth, or other information such as your education level or personal medical information ("Information") that you voluntarily provide to us and that is collected online through this Web site only.
We encourage you to read this Privacy Statement before using this Web site or submitting Information. By using this Web site, you acknowledge that you understand and agree to the terms of this Privacy Statement.
Information Voluntarily Provided by Users
You can visit much of the Web site without telling us who you are or providing us with Information. Some areas of the Web site allow you to contact us to ask questions or provide comments. When you communicate with us and request a response, we ask for certain Information. If you do not wish to be contacted after we have fulfilled your request, you may call 1-888-281-9014.
Some areas of the Web site may also require that you submit Information in order to access specific content, features, interactive tools, or services or to participate in a particular activity. For example, to create an online account or to subscribe to a newsletter, we may ask for Information so we can tailor our response to your request.
In addition, when you access certain interactive tools or services, you may be asked to provide Information. You may always choose not to provide the required Information, but then you may not be able to participate in that particular activity.
We may personalize and customize this Web site for certain visitors. If you provide Information about yourself via a contact form, you may find it customized with references to products and/or services that we believe may be of interest to you, based on your previous interactions and Information you have provided to us. If you do provide us with Information, you agree that we may contact you through a variety of means such as postal mail, phone, or e-mail unless you opt out of this service by contacting us as indicated below.
We may share your Information with one of our other Bristol-Myers Squibb and AstraZeneca affiliated companies. We may also occasionally transfer or share your Information with third parties and affiliates who provide services to Bristol-Myers Squibb and AstraZeneca. Such third parties have or will agree to only use the Information on behalf of Bristol-Myers Squibb and AstraZeneca.
Use and Disclosure of Non–Personally Identifiable Information
Bristol-Myers Squibb and AstraZeneca will not treat as confidential any information that you provide that is not personally identifiable, such as questions, comments, ideas, or suggestions. You should be aware that such information will be the sole property of Bristol-Myers Squibb and AstraZeneca. By providing such information to Bristol-Myers Squibb and AstraZeneca, you understand and agree that no relationship has been created between Bristol-Myers Squibb and AstraZeneca and you, and Bristol-Myers Squibb and AstraZeneca have no obligation to you whatsoever regarding that information.
Update and Correction of Information
Other than the limited type of Information described below under the Regulatory Requirements section, you may contact us to update or correct your Information or to opt out from our mailings and other services that you may have signed up for. To do so, please contact us at 1-888-281-9014.
Security
We take reasonable precautions to maintain the protection of Information collected through this Web site and used in accordance with this Privacy Statement. In addition to technical safeguards, we also use physical controls and procedures to safeguard your Information. However, we cannot guarantee that it is completely secure from people who might attempt to evade our security measures or intercept transmissions over the Internet. The use of this Web site is solely at your own risk.
Use of Cookies
We may store some information on your computer using a technique your browser supports called "cookies." The cookies are used for a variety of purposes, including, but not limited to, helping you log in (eg, remembering your user name if you register or log in), remembering some of your customized user preferences, to help us better understand how people use our Web site, and to help us improve our Web site. In some cases, this information will help us tailor content to your interests or help us avoid asking for the same information when you revisit our Web site. The cookies set by our Web sites are used only by our Web sites. To disable or limit the use of cookies, please refer to the options provided by your Internet browser. If you do so, however, some pages on this Web site may not work properly.
Web Beacons
A Web Beacon is a clear GIF (Graphics Interchange Format) image or pixel tag that companies place on their Web sites to allow an Internet advertising or audience measurement company to help them analyze their advertising campaigns and general usage patterns of visitors to their Web sites. Bristol-Myers Squibb and AstraZeneca use Web Beacons on some of their Web sites.
Web Server Logging and IP Addresses
With or without cookies, our Web site keeps track of usage data, such as the source address that a page request is coming from (ie, your IP address, domain name), date and time of the page request, the referring Web site (if any), and other parameters in the URL (eg, search criteria). We use this data to better understand Web site usage on the whole and to determine which areas of our Web site users prefer (eg, based on the number of visits to those areas). This information is stored in log files and is used by Bristol-Myers Squibb and AstraZeneca for statistical reporting.
Transfer of Control
Circumstances may arise where we decide to reorganize or divest part or all of our business or of a line of our business, including our information databases and Web sites, through a sale, divestiture, merger, acquisition, or other means of transfer. In any such circumstance, personally identifiable Information may be shared with, sold, transferred, rented, licensed, or otherwise provided or made available by us or on our behalf to actual or potential parties to, and in connection with, the contemplated transaction (without your consent or any further notice to you). In such circumstances, we will seek written assurances that Information submitted through this Web site will be protected appropriately.
Regulatory Requirements
If you contact us regarding your experience, or the experience of your patients, with the use of any of our products, we may use the Information you provide in submitting reports to the US Food and Drug Administration, and as otherwise required of us by law or governmental audit. You understand that, in order to comply with the law, Bristol-Myers Squibb and AstraZeneca may not be permitted to comply with your request to amend or remove Information that you provided to Bristol-Myers Squibb and AstraZeneca regarding an adverse event or reaction involving medicine, medical products, or medical devices.
Law Enforcement
In rare situations, we may be required by court order or other legal or regulatory process, or as otherwise required by law, to divulge Information to law enforcement authorities, the courts, or regulatory authorities. Bristol-Myers Squibb and AstraZeneca will cooperate in responding to such requests, in accordance with the regulatory or legal process, and will take appropriate measures to ensure that the requester understands the sensitive nature of any health-related Information they receive.
Bristol-Myers Squibb and AstraZeneca may also use Information to investigate and help prevent unlawful activity or activity that threatens the integrity and proper functioning of this Web site. Bristol-Myers Squibb and AstraZeneca may disclose your identity to third parties (such as the police) for these purposes. Bristol-Myers Squibb and AstraZeneca may monitor or record your communications with us for these, and quality control and training, purposes.
Privacy Policies Governing Linked Web Sites
As a convenience to our visitors, the Web site contains links to other Web sites that may offer useful information. This Internet Privacy Statement does not apply to your use of those other Web sites. Before using the linked Web sites, please review their Internet privacy statements to understand how they use and protect personally identifiable information.
Tell-a-Friend
You can choose to use a "tell-a-friend" or referral function on our Web site to let someone else know about this Web site or a product. In such case, we will ask for your friend's name and e-mail address, as well as Information about you. The Information that you may provide for a friend will be used to send an e-mail on your behalf and will not be collected or stored by
Bristol-Myers Squibb or AstraZeneca for any additional purpose.
Changes in Our Privacy Statement
Bristol-Myers Squibb and AstraZeneca may at any time revise this Privacy Statement by updating this posting. You are bound by any such revisions and should therefore periodically visit this page to review the most current Privacy Statement.
Online Privacy for Children
We are committed to protecting the privacy of children. We do not intend to collect personally identifiable Information from children under 13 years old. If a child has provided us with personally identifiable Information, the parent or guardian of that child may contact us at 1-888-281-9014.
Questions
If you have any questions about this Privacy Statement or other aspects of privacy on our Web site, please contact us at
1-888-281-9014.
Patient Information for Onglyza™ (saxagliptin)
Read the Patient Information that comes with Onglyza™ (saxagliptin) before you start taking it and each time you
get a refill. There may be new information. Reading this information does not take the place of talking with
your healthcare provider about your medical condition or treatment.
What is Onglyza?
Onglyza is a prescription medicine used with diet and exercise to control high
blood sugar (hyperglycemia) in adults with type 2 diabetes.
Onglyza lowers blood sugar by helping the body increase the level of insulin after meals.
Onglyza is unlikely to cause your blood sugar to be lowered to a dangerous level (hypoglycemia) because it does not work well when your blood sugar is low.
Onglyza has not been studied in children younger than 18 years old.
What should I tell my healthcare provider before taking Onglyza?
Before you take Onglyza, tell your healthcare provider about all of your
medical conditions, including if you:
- have type 1 diabetes. Onglyza should not be used to treat people with type 1 diabetes.
- have a history or risk for diabetic ketoacidosis (high levels of certain acids, known as ketones, in the blood or urine).
Onglyza should not be used for the treatment of diabetic ketoacidosis.
- are taking insulin. Onglyza has not been studied with insulin.
- are pregnant or plan to become pregnant. It is not known if Onglyza will harm your unborn baby.
If you are pregnant, talk with your healthcare provider about the best way to control your blood sugar while
you are pregnant.
- are breast-feeding or plan to breast-feed. Onglyza may be passed in your milk to your baby.
Talk with your healthcare provider about the best way to feed your baby while you take Onglyza.
Tell your healthcare provider about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.
Onglyza may affect the way other medicines work, and other medicines may affect how Onglyza works. Contact your healthcare provider if you will be starting or stopping certain other types of medications, such as antibiotics, or medicines that treat fungus or HIV/AIDS, because your dose of Onglyza might need to be changed.
How should I take Onglyza?
- Take Onglyza by mouth one time each day exactly as directed by your healthcare provider. Do not change your dose without talking to your healthcare provider.
- Onglyza can be taken with or without food.
- During periods of stress on the body, such as:
- fever
- trauma
- infection
- surgery
Contact your healthcare provider right away as your medication needs may change.
- Your healthcare provider should test your blood to measure how well your kidneys work.
You may need a lower dose of Onglyza if your kidneys are not working well.
- Your healthcare provider may prescribe Onglyza along with other medicines that lower blood sugar.
- Follow your healthcare provider's instructions for treating blood sugar that is too low (hypoglycemia). Talk to your healthcare provider if
low blood sugar is a problem for you.
- If you miss a dose of Onglyza, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose.
Just take the next dose at your regular time. Do not take two doses at the same time unless your healthcare provider tells you to do so.
Talk to your healthcare provider if you have questions about a missed dose.
- If you take too much Onglyza, call your healthcare provider or Poison Control Center at
1-800-222-1222, or go to the
nearest hospital emergency room right away.
What are the possible side effects of Onglyza?
Common side effects of Onglyza include:
- upper respiratory tract infection
Low blood sugar (hypoglycemia) may become worse in people who already take another
medication to treat diabetes, such as sulfonylureas. Tell your healthcare provider if you take other diabetes medicines.
If you have symptoms of low blood sugar, you should check your blood sugar and treat if low, then call your healthcare provider.
Symptoms of low blood sugar include:
- shaking
- sweating
- rapid heartbeat
- change in vision
- hunger
- headache
- change in mood
Swelling or fluid retention in your hands, feet, or ankles (peripheral edema) may become worse in people who also take a thiazolidinedione to treat diabetes. If you do not know whether you are already on this type of medication, ask your healthcare provider.
Allergic (hypersensitivity) reactions, such as rash, hives, and swelling of the face, lips, and throat. If you have these symptoms, stop taking Onglyza and call your healthcare provider right away.
These are not all of the possible side effects of Onglyza. Tell your healthcare provider if you have any side effects that bother you or that do not go away. For more information, ask your healthcare provider.
Call your healthcare provider for medical advice about side effects. You may report side effects to the FDA at
1-800-FDA-1088.
How should I store Onglyza?
Store Onglyza between 68° to 77°F (20° to 25°C).
Keep Onglyza and all medicines out of the reach of children.
General information about the use of Onglyza
Medicines are sometimes prescribed for conditions that are not mentioned in the patient information. Do not use Onglyza for a condition for which it was not prescribed. Do not give Onglyza to other people, even if they have the same symptoms you have. It may harm them.
This
patient leaflet summarizes the most important information about Onglyza. If you would like to know more information about Onglyza, talk with your healthcare provider. You can ask your healthcare provider for additional information about Onglyza that is written for healthcare professionals. For more information, call 1-800-ONGLYZA.
What are the ingredients of Onglyza?
Active ingredient: saxagliptin
Inactive ingredients: lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, and magnesium stearate. In addition, the film coating contains the following inactive ingredients: polyvinyl alcohol, polyethylene glycol, titanium dioxide, talc, and iron oxides.
What is type 2 diabetes?
Type 2 diabetes is a condition in which your body does not make enough insulin, and the insulin that your body produces does not work as well as it should. Your body can also make too much sugar. When this happens, sugar (glucose) builds up in the blood. This can lead to serious medical problems.
The main goal of treating diabetes is to lower your blood sugar to a normal level.
High blood sugar can be lowered by diet and exercise, and by certain medicines when necessary.
Please see
US Full Prescribing Information, including
Patient Information for Onglyza (saxagliptin) and discuss with your doctor.
Onglyza is one of several treatment options your doctor may consider.
You are encouraged to report negative side effects of prescription drugs to the FDA.